NIH-funded research R01 grant

Developing materials and tools to repair vocal fold tissue

Official title: Bioprintable composite materials and microfluidic tools for vocal fold restoration and repair

Funded at Mcgill University · NIH-11003674 · Data updated 2026-11-12

This study is exploring new ways to help people with voice problems by developing special materials that can repair damaged vocal cords, making it easier for them to heal and get their voices back.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMcgill University
NIH-funded
Lab location1 site (Montreal, Canada)
Project startJanuary 1, 2021
Project endDecember 31, 2025
Funding year2025
Award (this year)$491,308
NIH project number5R01DC018577-05
Project IDNIH-11003674 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals of all ages experiencing voice disorders due to injury or other medical conditions.

Less likely to help

Patients with voice disorders not related to tissue damage or those who have other underlying health issues may not benefit from this research.

What this research studies

This research focuses on creating innovative biomaterials and bioprinting technologies to repair damaged vocal fold tissues. By utilizing composite bioactive hydrogels, the team aims to enhance the healing process for individuals suffering from voice disorders. The approach involves both injectable and printed materials that can be tailored to specific lesions, potentially improving recovery outcomes. The research includes extensive laboratory testing to ensure the effectiveness and safety of these new materials.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments for voice disorders, improving communication abilities for many patients.

How similar studies have gone: Previous research in tissue engineering and biomaterials has shown promise in similar applications, suggesting a potential for success in this novel approach.

Where this research is happening

  • Mcgill University
    Montreal, Canada
    Active

Researchers

  • Principal investigator: Mongeau, Luc — Mcgill University
  • Study coordinator: Mongeau, Luc

Related research

Other NIH-funded projects on the same topics.

  • How loneliness affects brain aging and Alzheimer's disease risk

    This study is looking at how feeling lonely might affect the brains of older adults who are at risk for Alzheimer's disease, hoping to find clues that could help us understand and predict changes in brain health.

    NIH research Mcgill University · Montreal, Canada · NIH-11081953

  • The effects of insecticides on child growth and puberty in South Africa

    This study looks at how the insecticides used in homes to fight malaria might be affecting the growth and development of children in South Africa, especially in relation to rising obesity and early puberty, so we can better understand any health risks for kids living in these areas.

    NIH research Mcgill University · Montreal, Canada · NIH-10976429

  • How loneliness affects brain aging and Alzheimer's disease risk

    This study is looking at how feeling lonely might affect brain health as we age, especially for older adults who are at risk for Alzheimer's, to help us understand if loneliness can lead to changes in the brain and speed up memory problems.

    NIH research Mcgill University · Montreal, Canada · NIH-10836473

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.